DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

1 API Suppliers, 1 USDMF

1 API Suppliers
1 USDMF

FINISHED DOSAGE FORMULATIONS

2 FDF Dossiers, 2 FDA Orange Book

2 FDF Dossiers
2 FDA Orange Book

PATENTS & EXCLUSIVITIES

3 Health Canada Patents

patents
3 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM

otherSolutions
1 EDQM

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Iotrol, 79770-24-4, Isovist, Osmovist, Isovist 300, Dl-3117

Molecular Formula

C₃₇H₄₈I₆N₆O₁₈

Molecular Weight

1626.2 g/mol

InChI Key

XUHXFSYUBXNTHU-UHFFFAOYSA-N

FDA UNII

16FL47B687

Nonionic, isotonic contrast medium designed for intrathecal use.

1 2D Structure

Iotrolan

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

2,4,6-triiodo-5-[methyl-[3-oxo-3-[2,4,6-triiodo-N-methyl-3,5-bis(1,3,4-trihydroxybutan-2-ylcarbamoyl)anilino]propanoyl]amino]-1-N,3-N-bis(1,3,4-trihydroxybutan-2-yl)benzene-1,3-dicarboxamide

2.1.2 InChI

InChI=1S/C37H48I6N6O18/c1-48(32-28(40)22(34(64)44-12(4-50)16(58)8-54)26(38)23(29(32)41)35(65)45-13(5-51)17(59)9-55)20(62)3-21(63)49(2)33-30(42)24(36(66)46-14(6-52)18(60)10-56)27(39)25(31(33)43)37(67)47-15(7-53)19(61)11-57/h12-19,50-61H,3-11H2,1-2H3,(H,44,64)(H,45,65)(H,46,66)(H,47,67)

2.1.3 InChI Key

XUHXFSYUBXNTHU-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CN(C1=C(C(=C(C(=C1I)C(=O)NC(CO)C(CO)O)I)C(=O)NC(CO)C(CO)O)I)C(=O)CC(=O)N(C)C2=C(C(=C(C(=C2I)C(=O)NC(CO)C(CO)O)I)C(=O)NC(CO)C(CO)O)I

2.2 Other Identifiers

2.2.1 UNII

16FL47B687

2.3 Synonyms

2.3.1 MeSH Synonyms

1. Dl 3-117

2. Dl 3117

3. Dl-3-117

4. Iotrol

5. Isovist

6. Isovist 300

7. Osmovist

2.3.2 Depositor-Supplied Synonyms

1. Iotrol

2. 79770-24-4

3. Isovist

4. Osmovist

5. Isovist 300

6. Dl-3117

7. Compound Zk 39482

8. Zk 39 482

9. 1,3-benzenedicarboxamide, 5,5'-((1,3-dioxo-1,3-propanediyl)bis(methylimino))bis(n,n'-bis(2,3-dihydroxy-1-(hydroxymethyl)propyl)-2,4,6-triiodo-

10. Iotrovist

11. 16fl47b687

12. 2,4,6-triiodo-5-[methyl-[3-oxo-3-[2,4,6-triiodo-n-methyl-3,5-bis(1,3,4-trihydroxybutan-2-ylcarbamoyl)anilino]propanoyl]amino]-1-n,3-n-bis(1,3,4-trihydroxybutan-2-yl)benzene-1,3-dicarboxamide

13. 5,5'-(malonylbis(methylimino))bis(n,n'-bis(2,3-dihydroxy-1-(hydroxymethyl)propyl)-2,4,6-triiodoisophthalamide)

14. Zk-39482

15. Zk-39-482

16. Iotrolanum [latin]

17. Osmovist 190

18. Osmovist 240

19. Iotrolanum

20. Iotrolum

21. Iotrolum [inn-latin]

22. Dl 3-117

23. Sh 437

24. Zk 39482

25. Unii-16fl47b687

26. Iotrolan(isovist)

27. Iotrolan [usan:inn:ban:jan]

28. Iotrolan [usan]

29. Iotrolan [inn]

30. Iotrolan [jan]

31. Iotrolan [mi]

32. Iotrolan [vandf]

33. Isovist 300 (tn)

34. Iotrolan [mart.]

35. Iotrolan [who-dd]

36. Schembl25535

37. Iotrolan (jan/usan/inn)

38. Iotrolan [orange Book]

39. Iotrolan For System Suitability

40. Iotrolan [ep Monograph]

41. Chembl1200555

42. Dtxsid0023165

43. Chebi:31715

44. Sh-l-437d

45. Db09487

46. Ft-0754152

47. D01714

48. 770i244

49. Q6064149

50. 5,5'-[(1,3-dioxopropane-1,3-diyl)bis(methylimino)]bis{n,n'-bis[2,3-dihydroxy-1-(hydroxymethyl)propyl]-2,4,6-triiodobenzene-1,3-dicarboxamide}

2.4 Create Date

2005-03-25

3 Chemical and Physical Properties

Molecular Formula	C₃₇H₄₈I₆N₆O₁₈
Molecular Weight	1626.2 g/mol
XLogP3	-4.2
Hydrogen Bond Donor Count	16
Hydrogen Bond Acceptor Count	18
Rotatable Bond Count	24
Exact Mass	1625.7293 g/mol
Monoisotopic Mass	1625.7293 g/mol
Topological Polar Surface Area	400 Å²
Heavy Atom Count	67
Formal Charge	0
Complexity	1450
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	8
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1